Montana Code Annotated
Chapter 32. Controlled Substances
Part 2. Scheduling of Dangerous Drugs

50-32-201. General criteria to be considered - 50-32-201. General criteria to be considered. In making a determination...

50-32-202. Designation of drug as dangerous drug - 50-32-202. Designation of drug as dangerous drug. After considering the...

50-32-203. Effect of rescheduling under federal law - 50-32-203. Effect of rescheduling under federal law. If any drug...

50-32-204. Immediate precursors - 50-32-204. Immediate precursors. If the board designates a drug as...

50-32-205. Nonprescription drugs not to be scheduled - 50-32-205. Nonprescription drugs not to be scheduled. The board shall...

50-32-206. Use of names of scheduled drugs - 50-32-206. Use of names of scheduled drugs. The dangerous drugs...

50-32-207. Order forms for drugs in Schedules I and II - 50-32-207. Order forms for drugs in Schedules I and II....

50-32-208. Prescription and medical requirements for scheduled drugs -- penalty - 50-32-208. Prescription and medical requirements for scheduled drugs -- penalty....

50-32-209. Republication of schedules - 50-32-209. Republication of schedules. The board shall revise and the...

50-32-210. through 50-32-220 reserved - 50-32-210 through 50-32-220 reserved.

50-32-221. Criteria for placement of drug in Schedule I - 50-32-221. Criteria for placement of drug in Schedule I. The...

50-32-222. Specific dangerous drugs included in Schedule I - 50-32-222. Specific dangerous drugs included in Schedule I. Schedule I...

50-32-223. Criteria for placement of drug in Schedule II - 50-32-223. Criteria for placement of drug in Schedule II. The...

50-32-224. Specific dangerous drugs included in Schedule II - 50-32-224. Specific dangerous drugs included in Schedule II. Schedule II...

50-32-225. Criteria for placement of drug in Schedule III - 50-32-225. Criteria for placement of drug in Schedule III. The...

50-32-226. Specific dangerous drugs included in Schedule III - 50-32-226. Specific dangerous drugs included in Schedule III. Schedule III...

50-32-227. Board authorized to exempt certain compounds, mixtures, or preparations from Schedule III - 50-32-227. Board authorized to exempt certain compounds, mixtures, or preparations...

50-32-228. Criteria for placement of drug in Schedule IV - 50-32-228. Criteria for placement of drug in Schedule IV. The...

50-32-229. Specific dangerous drugs included in Schedule IV - 50-32-229. Specific dangerous drugs included in Schedule IV. Schedule IV...

50-32-230. Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV - 50-32-230. Board authorized to exempt certain compounds, mixtures, or preparations...

50-32-231. Criteria for placement of drug in Schedule V - 50-32-231. Criteria for placement of drug in Schedule V. The...

50-32-232. Specific dangerous drugs included in Schedule V - 50-32-232. Specific dangerous drugs included in Schedule V. Schedule V...

50-32-233. Exempt anabolic steroid products - 50-32-233. Exempt anabolic steroid products. The following anabolic steroid-containing compounds,...